期刊文献+
共找到6篇文章
< 1 >
每页显示 20 50 100
ON UNIVALENT BLOCH FUNCTIONS
1
作者 乌兰哈斯 《Acta Mathematica Scientia》 SCIE CSCD 2001年第1期37-40,共4页
A new characterization of univalent Bloch functions is given by investigating the growth order of an essentially increasing function. Our contribution can be considered as a slight improvement of the well-known Pommer... A new characterization of univalent Bloch functions is given by investigating the growth order of an essentially increasing function. Our contribution can be considered as a slight improvement of the well-known Pommerenke's result and its all generalizations, and the proof presented in this paper is independently developed. 展开更多
关键词 univalent Bloch functions essentially increasing functions Q(p) spaces
下载PDF
健胃消胀片治疗非酒精性脂肪性肝病临床研究 被引量:1
2
作者 卢晓敏 袁瑞兴 +2 位作者 王家华 房志科 董明国 《新中医》 CAS 2017年第12期41-43,共3页
目的:观察健胃消胀片治疗非酒精性脂肪性肝病(NAFLD)的临床效果。方法:纳入60例NAFLD患者,随机分为治疗组和对照组各30例,治疗组服用健胃消胀片治疗,对照组服用易善复胶囊治疗,2组患者均治疗12周,观察2组患者的临床主要症状积分、肝功... 目的:观察健胃消胀片治疗非酒精性脂肪性肝病(NAFLD)的临床效果。方法:纳入60例NAFLD患者,随机分为治疗组和对照组各30例,治疗组服用健胃消胀片治疗,对照组服用易善复胶囊治疗,2组患者均治疗12周,观察2组患者的临床主要症状积分、肝功能指标[谷丙转氨酶(ALT)、谷草转氨酶(AST)]、血脂指标[甘油三酯(TG)、总胆固醇(TC)]及肝脏超声等的变化。结果:治疗后,治疗组总有效率为90.00%,对照组总有效率为83.33%。2组疗效比较,差异无统计学意义(P>0.05)。2组ALT、AST水平均较治疗前下降(P<0.05),治疗组2项指标水平均低于对照组(P<0.05)。2组TC、TG水平与主症积分、肝脏超声积分均较治疗前下降(P<0.05),2组TC、TG、肝脏超声积分比较,差异均无统计学意义(P>0.05),治疗组主症积分低于对照组(P<0.05)。结论:健胃消胀片治疗NAFLD在临床疗效及改善血脂代谢方面与易善复胶囊相当,而在改善临床症状及肝功能等方面有明确优势。 展开更多
关键词 非酒精性脂肪性肝病(NAFLD) 升清降浊法 健胃消胀片 易善复胶囊 肝功能 血脂
下载PDF
Tumor suppressor p53 functions as an essential antiviral molecule against Japanese encephalitis virus 被引量:1
3
作者 Xufang Deng Jianchao Wei +8 位作者 Zixue Shi Wenjun Yan Zhuanchang Wu Donghua Shao Beibei Li Ke Liu Xiaodu Wang Yafeng Qiu Zhiyong Ma 《Journal of Genetics and Genomics》 SCIE CAS CSCD 2016年第12期709-712,共4页
Japanese encephalitis virus (jEV) is a mosquito-borne virus of the family Flaviviridae. It is the causative agent of Japanese encephalitis with approximately 50,000 infection cases and 10,000 fatal cases annually in... Japanese encephalitis virus (jEV) is a mosquito-borne virus of the family Flaviviridae. It is the causative agent of Japanese encephalitis with approximately 50,000 infection cases and 10,000 fatal cases annually in Asia (Erlanger et al., 2009). Although liveattenuated JEV vaccine has been developed and used for human and pig vaccination, JE occurs epidemically or sporadically in some developing countries or even in vaccinated areas (Solomon, 2006). Host resistance factors play an important role in the outcome of viral infection. 展开更多
关键词 RNA Tumor suppressor p53 functions as an essential antiviral molecule against Japanese encephalitis virus PFU NC
原文传递
FERM domain phosphorylation and endogenous 3'UTR are not essential for regulating the function and subcellular localization of polarity protein Crumbs
4
作者 Haowei Cao Rui Xu +3 位作者 Qiping Shi Dandan Zhang Juan Huang Yang Hong 《Journal of Genetics and Genomics》 SCIE CAS CSCD 2017年第8期409-412,共4页
In the past two decades, extensive studies have focused on a group of so-called polarity proteins that play conserved and essential functions in establishing and maintaining cell polarity in epithelial cells. Among th... In the past two decades, extensive studies have focused on a group of so-called polarity proteins that play conserved and essential functions in establishing and maintaining cell polarity in epithelial cells. Among them, Crumbs (Crb) is the only trans- membrane polarity protein characterized to date (Tepass et al., 展开更多
关键词 FERM domain phosphorylation and endogenous 3’UTR are not essential for regulating the function and subcellular localization of polarity protein Crumbs UTR
原文传递
The new chimeric chiron genes evolved essential roles in zebrafish embryonic development by regulating NAD+ levels 被引量:1
5
作者 Chengchi Fang Xiaoni Gan +1 位作者 Chengjun Zhang Shunping He 《Science China(Life Sciences)》 SCIE CAS CSCD 2021年第11期1929-1948,共20页
The origination of new genes is important for generating genetic novelties for adaptive evolution and biological diversity.However, their potential roles in embryonic development, evolutionary processes into ancient n... The origination of new genes is important for generating genetic novelties for adaptive evolution and biological diversity.However, their potential roles in embryonic development, evolutionary processes into ancient networks, and contributions to adaptive evolution remain poorly investigated. Here, we identified a novel chimeric gene family, the chiron family, and explored its genetic basis and functional evolution underlying the adaptive evolution of Danioninae fishes. The ancestral chiron gene originated through retroposition of nampt in Danioninae 48–54 million years ago(Mya) and expanded into five duplicates(chiron1–5) in zebrafish 1–4 Mya. The chiron genes(chirons) likely originated in embryonic development and gradually extended their expression in the testis. Functional experiments showed that chirons were essential for zebrafish embryo development. By integrating into the NAD^(+) synthesis pathway, chirons could directly catalyze the NAD^(+) rate-limiting reaction and probably impact two energy metabolism genes(nmnat 1 and naprt) to be under positive selection in Danioninae fishes. Together,these results mainly demonstrated that the origin of new chimeric chiron genes may be involved in adaptive evolution by integrating and impacting the NAD^(+) biosynthetic pathway. This coevolution may contribute to the physiological adaptation of Danioninae fishes to widespread and varied biomes in Southeast Asian. 展开更多
关键词 new chimeric genes essential function NAD^(+)rate-limiting enzyme coevolution
原文传递
不同剂量易善复治疗肝硬化的疗效及安全性研究 被引量:1
6
作者 陶琴琴 赵亚静 +2 位作者 卢英 杨晓明 郑长青 《现代生物医学进展》 CAS 2017年第28期5476-5479,共4页
目的:探讨不同剂量的多烯磷脂酰胆碱(易善复)对肝硬化的治疗效果及其安全性。方法:以2016年~2017年在我院就诊的70例单纯肝炎后肝硬化(VC)和酒精性肝硬化(AC)患者为研究对象,采用随机数字表法将其随机分为小剂量组和大剂量组,每组35例... 目的:探讨不同剂量的多烯磷脂酰胆碱(易善复)对肝硬化的治疗效果及其安全性。方法:以2016年~2017年在我院就诊的70例单纯肝炎后肝硬化(VC)和酒精性肝硬化(AC)患者为研究对象,采用随机数字表法将其随机分为小剂量组和大剂量组,每组35例。小剂量组予易善复10 m L+5%葡萄糖注射液250 m L静滴,大剂量组予易善复20 m L+5%葡萄糖注射液250 m L静滴。观察两组治疗前后临床症状、血尿常规、肾功能、肝功能指标、腹腔彩超的变化情况。结果:两组患者治疗后肝功能指标谷丙转氨酶(ALT)、白蛋白(ALB)、总胆红素(TBIL)、谷草转氨酶(AST)、碱性磷酸酶(ALP)均较治疗前明显改善(P<0.05),且大剂量组各项指标水平均明显优于小剂量组(P<0.05);大剂量组治疗肝硬化的总有效率为88.6%,显著高于小剂量组的(68.6%,P<0.05)。两组治疗过程中均未见明显药物副反应。结论:与小剂量易善复相比,大剂量易善复更能改善单纯肝炎后肝硬化和酒精性肝硬化患者的肝功能,提高药物疗效的同时不增加药物副反应,安全性高。 展开更多
关键词 易善复 肝硬化 不同剂量 肝功能
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部